Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.44 - $1.22 $1.13 Million - $3.12 Million
-2,559,735 Reduced 87.63%
361,245 $249,000
Q4 2023

Feb 14, 2024

BUY
$0.23 - $1.74 $311,975 - $2.36 Million
1,356,416 Added 86.7%
2,920,980 $1.49 Million
Q2 2023

Aug 14, 2023

BUY
$1.5 - $3.04 $1.58 Million - $3.21 Million
1,055,769 Added 207.5%
1,564,564 $2.52 Million
Q1 2023

May 15, 2023

BUY
$2.8 - $5.46 $1.04 Million - $2.02 Million
369,715 Added 265.83%
508,795 $1.48 Million
Q4 2022

Feb 14, 2023

BUY
$2.85 - $5.18 $11,015 - $20,020
3,865 Added 2.86%
139,080 $456,000
Q3 2022

Nov 14, 2022

BUY
$2.85 - $8.73 $205,807 - $630,419
72,213 Added 114.62%
135,215 $511,000
Q2 2022

Aug 15, 2022

SELL
$4.69 - $9.84 $1.79 Million - $3.76 Million
-382,079 Reduced 85.84%
63,002 $491,000
Q1 2022

May 16, 2022

BUY
$8.44 - $16.89 $3.4 Million - $6.81 Million
403,398 Added 967.78%
445,081 $4.14 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $19.89 $919,440 - $1.24 Million
-62,547 Reduced 60.01%
41,683 $657,000
Q3 2021

Nov 15, 2021

SELL
$11.99 - $17.9 $3.13 Million - $4.67 Million
-261,067 Reduced 71.47%
104,230 $1.87 Million
Q2 2021

Aug 16, 2021

SELL
$12.89 - $16.58 $929,072 - $1.2 Million
-72,077 Reduced 16.48%
365,297 $5.68 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $20.72 $3.9 Million - $5.77 Million
278,495 Added 175.29%
437,374 $6.28 Million
Q4 2020

Feb 16, 2021

SELL
$12.67 - $26.23 $1.83 Million - $3.79 Million
-144,537 Reduced 47.64%
158,879 $3.12 Million
Q3 2020

Nov 16, 2020

BUY
$11.92 - $15.87 $3.62 Million - $4.82 Million
303,416 New
303,416 $3.93 Million
Q2 2020

Aug 14, 2020

SELL
$7.53 - $14.93 $494,231 - $979,930
-65,635 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$5.69 - $17.78 $669,923 - $2.09 Million
-117,737 Reduced 64.21%
65,635 $559,000
Q4 2019

Feb 14, 2020

BUY
$10.89 - $16.79 $2 Million - $3.08 Million
183,372 New
183,372 $3.02 Million
Q3 2019

Nov 14, 2019

SELL
$12.03 - $19.94 $2.34 Million - $3.88 Million
-194,380 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$19.05 - $41.04 $645,452 - $1.39 Million
33,882 Added 21.11%
194,380 $3.91 Million
Q1 2019

May 14, 2019

BUY
$28.4 - $41.74 $4.2 Million - $6.18 Million
147,971 Added 1181.22%
160,498 $6.38 Million
Q4 2018

Feb 14, 2019

BUY
$30.9 - $42.97 $387,084 - $538,285
12,527 New
12,527 $435,000
Q4 2017

Feb 14, 2018

SELL
$13.2 - $18.1 $286,624 - $393,023
-21,714 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$13.25 - $17.05 $287,710 - $370,223
21,714
21,714 $359,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.15B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.